The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

This stock is worth watching for several compelling reasons, including a gamechanging acquisition, ahead of its upcoming earnings.

Waystar Holding Corp. shows revenue growth and strategic expansion with the Iodine acquisition. Click for why high valuations and muted growth may temper WAY's appeal.

Louisville's newest public company raises nearly $1 billion © 2025 American City Business Journals. All rights reserved. Use ...

Waystar to acquire Iodine Software for $1.25 billion to enhance AI tools; deal expected to be accretive to growth and margins by 2027.

Waystar has agreed to acquire Iodine Software, an Austin-based provider of AI-powered clinical intelligence, for $1.25 billion. The sellers include majority shareholder Advent International and Iodine ...

Waystar has signed a definitive agreement to acquire AI-powered revenue cycle management company Iodine Software. The proposed $1.25 billion deal will be funded with a 50/50 mix of cash and stock ...

The acquisition will enable Waystar to automate tasks such as utilisation management and clinical documentation integrity.

Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced a definitive agreement to acquire ...

Waystar plans to acquire AI-driven revenue cycle management company Iodine Software, its first acquisition since going public ...

Healthcare-software company Waystar has agreed to buy private-equity backed Iodine Software for $1.25 billion, including debt ...

Waystar (WAY) said it will acquire health AI software company, Iodine Software, for a total enterprise value of $1.25B. The ...